phellodendron amurense bark extract
extract of bark of the phellodendron, phellodendron amurense, rutaceae
Identification
| Name | phellodendron amurense bark extract |
| CAS Number | 164288-52-2 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic ingredient for skin conditioning |
| Recommendation for phellodendron amurense bark extract usage levels up to | not for fragrance use. |
| Recommendation for phellodendron amurense bark extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
extract of bark of the phellodendron, phellodendron amurense, rutaceae
phellodendron extract
PubMed:
Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer.
PubMed:
Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.
PubMed:
STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.
PubMed:
Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects.
PubMed:
Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
PubMed:
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management.
PubMed:
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
PubMed:
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
PubMed:
Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.